Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 7/2020

01.07.2020 | Original Article

Whole-vessel coronary 18F-sodium fluoride PET for assessment of the global coronary microcalcification burden

verfasst von: Jacek Kwiecinski, Sebastien Cadet, Marwa Daghem, Martin L. Lassen, Damini Dey, Marc R. Dweck, Daniel S. Berman, David E. Newby, Piotr J. Slomka

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

18F-sodium fluoride (18F-NaF) has shown promise in assessing disease activity in coronary arteries, but currently used measures of activity – such as maximum target to background ratio (TBRmax) – are defined by single pixel count values. We aimed to develop a novel coronary-specific measure of 18F-NaF PET reflecting activity throughout the entire coronary vasculature (coronary microcalcification activity [CMA]).

Methods

Patients with recent myocardial infarction and multi-vessel coronary artery disease underwent 18F-NaF PET and coronary CT angiography. We assessed the association between coronary 18F-NaF uptake (both TBRmax and CMA) and coronary artery calcium scores (CACS) as well as low attenuation plaque (LAP, attenuation < 30 Hounsfield units) volume.

Results

In 50 patients (64% males, 63 ± 7 years), CMA and TBRmax were higher in vessels with LAP compared to those without LAP (1.09 [0.02, 2.34] versus 0.0 [0.0, 0.0], p < 0.001 and 1.23 [1.16, 1.37] versus 1.04 [0.93, 1.11], p < 0.001). Compared to a TBRmax threshold of 1.25, CMA > 0 had a higher diagnostic accuracy for detection of LAP: sensitivity of 93.1 (83.3–98.1)% versus 58.6 (44.9–71.4)% and a specificity of 95.7 (88.0–99.1)% versus 80.0 (68.7–88.6)% (both p < 0.001).
18F-NaF uptake assessed by CMA correlated more closely with LAP (r = 0.86, p < 0.001) than the CT calcium score (r = 0.39, p < 0.001), with these associations outperforming those observed for TBRmax values (LAP r = 0.63, p < 0.001; CT calcium score r = 0.30, p < 0.001).

Conclusions

Automated assessment of disease activity across the entire coronary vasculature is feasible using 18F-NaF CMA, providing a single measurement that has closer agreement with CT markers of plaque vulnerability than more traditional measures of plaque activity.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Go AS, Mozaffarian D, Roger VL, for theAmerican Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;129:e28–e292.CrossRef Go AS, Mozaffarian D, Roger VL, for theAmerican Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;129:e28–e292.CrossRef
6.
Zurück zum Zitat Williams MC, Moss AJ, Dweck M, et al. Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study. J Am Coll Cardiol. 2019;73:291–301.CrossRef Williams MC, Moss AJ, Dweck M, et al. Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study. J Am Coll Cardiol. 2019;73:291–301.CrossRef
7.
Zurück zum Zitat Ferencik M, Mayrhofer T, Bittner DO, et al. Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial. JAMA Cardiol. 2018;3:144–52.CrossRef Ferencik M, Mayrhofer T, Bittner DO, et al. Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial. JAMA Cardiol. 2018;3:144–52.CrossRef
13.
Zurück zum Zitat Beheshti M, Saboury B, Mehta N. Detection and global quantification of cardiovascular molecular calcification by fluoro-18-fluoride positron emission tomography/computed tomography—a novel concept. Hell J Nucl Med. 2011;14:114–20.PubMed Beheshti M, Saboury B, Mehta N. Detection and global quantification of cardiovascular molecular calcification by fluoro-18-fluoride positron emission tomography/computed tomography—a novel concept. Hell J Nucl Med. 2011;14:114–20.PubMed
14.
Zurück zum Zitat Blomberg BA, Thomassen A, de Jong PA, et al. Impact of personal characteristics and technical factors on quantification of sodium 18F-fluoride uptake in human arteries: prospective evaluation of healthy subjects. J Nucl Med. 2015;56:1534–40.CrossRef Blomberg BA, Thomassen A, de Jong PA, et al. Impact of personal characteristics and technical factors on quantification of sodium 18F-fluoride uptake in human arteries: prospective evaluation of healthy subjects. J Nucl Med. 2015;56:1534–40.CrossRef
15.
Zurück zum Zitat Kwiecinski J, Adamson PD, Lassen ML, et al. Feasibility of coronary 18F-sodium fluoride PET assessment with the utilization of previously acquired CT angiography. Circ Cardiovasc Imaging. 2018;11(12):e008325.CrossRef Kwiecinski J, Adamson PD, Lassen ML, et al. Feasibility of coronary 18F-sodium fluoride PET assessment with the utilization of previously acquired CT angiography. Circ Cardiovasc Imaging. 2018;11(12):e008325.CrossRef
16.
Zurück zum Zitat Leipsic J, Abbara S, Achenbach S, Cury R, Earls JP, Mancini GJ, et al. SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. JCCT. 2014;8:342–58. Leipsic J, Abbara S, Achenbach S, Cury R, Earls JP, Mancini GJ, et al. SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. JCCT. 2014;8:342–58.
18.
Zurück zum Zitat Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–32.CrossRef Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–32.CrossRef
19.
Zurück zum Zitat Hell MM, Motwani M, Otaki Y, et al. Quantitative global plaque characteristics from coronary computed tomography angiography for the prediction of future cardiac mortality during long-term follow-up. Eur Heart J Cardiovasc Imaging. 2017;18:1331–9.CrossRef Hell MM, Motwani M, Otaki Y, et al. Quantitative global plaque characteristics from coronary computed tomography angiography for the prediction of future cardiac mortality during long-term follow-up. Eur Heart J Cardiovasc Imaging. 2017;18:1331–9.CrossRef
21.
Zurück zum Zitat Doris MK, Otaki Y, Krishnan SK, Kwiecinski J, Rubeaux M, Alessio A et al. Optimization of reconstruction and quantification of motion-corrected coronary PET-CT. J Nucl Cardiol 2018. Doris MK, Otaki Y, Krishnan SK, Kwiecinski J, Rubeaux M, Alessio A et al. Optimization of reconstruction and quantification of motion-corrected coronary PET-CT. J Nucl Cardiol 2018.
23.
Zurück zum Zitat Steven ML, Yusuf E, Timothy A, et al. Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging: The Visual Response Score and the Change in Total Lesion Glycolysis. Clin Positron Imaging. 2(3):159–71. Steven ML, Yusuf E, Timothy A, et al. Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging: The Visual Response Score and the Change in Total Lesion Glycolysis. Clin Positron Imaging. 2(3):159–71.
27.
Zurück zum Zitat Han JH, Lim SY, Lee MS, et al. Sodium [18F]fluoride PET/CT in myocardial infarction. Mol Imaging Biol. 2015;17:214–21.CrossRef Han JH, Lim SY, Lee MS, et al. Sodium [18F]fluoride PET/CT in myocardial infarction. Mol Imaging Biol. 2015;17:214–21.CrossRef
28.
Zurück zum Zitat Giovanna Trivieri M, Dweck MR, Abgral R, Robson PM, et al. 18F-sodium fluoride PET/MR for the assessment of cardiac amyloidosis. J Am Coll Cardiol. 2016;68:2712–4.CrossRef Giovanna Trivieri M, Dweck MR, Abgral R, Robson PM, et al. 18F-sodium fluoride PET/MR for the assessment of cardiac amyloidosis. J Am Coll Cardiol. 2016;68:2712–4.CrossRef
29.
Zurück zum Zitat Marchesseau S, Seneviratna A, Sjoholm AT, et al. Hybrid PET/CT and PET/MRI imaging of vulnerable coronary plaque and myocardial scar tissue in acute myocardial infarction. J Nucl Cardiol. 2017. Marchesseau S, Seneviratna A, Sjoholm AT, et al. Hybrid PET/CT and PET/MRI imaging of vulnerable coronary plaque and myocardial scar tissue in acute myocardial infarction. J Nucl Cardiol. 2017.
30.
Zurück zum Zitat Chen HHW, Chiu N-T. Su W-Cet al. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non–small cell lung cancer. Radiology. 2012;264(2):559–66.CrossRef Chen HHW, Chiu N-T. Su W-Cet al. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non–small cell lung cancer. Radiology. 2012;264(2):559–66.CrossRef
31.
Zurück zum Zitat Frings V, van Velden FHP, Velasquez LM, et al. Repeatability of metabolically active tumor volume measurements with FDG PET / CT in advanced gastrointestinal malignancies: a multicenter study. Radiology. 2014;273(2):539–48.CrossRef Frings V, van Velden FHP, Velasquez LM, et al. Repeatability of metabolically active tumor volume measurements with FDG PET / CT in advanced gastrointestinal malignancies: a multicenter study. Radiology. 2014;273(2):539–48.CrossRef
32.
Zurück zum Zitat Kramer GM, Frings V, Hoetjes N, et al. Repeatability of quantitative whole-body 18F-FDG PET/CT uptake measures as function of uptake interval and lesion selection in non-small cell lung cancer patients. J Nucl Med. 2016;57(9):1343–9.CrossRef Kramer GM, Frings V, Hoetjes N, et al. Repeatability of quantitative whole-body 18F-FDG PET/CT uptake measures as function of uptake interval and lesion selection in non-small cell lung cancer patients. J Nucl Med. 2016;57(9):1343–9.CrossRef
33.
Zurück zum Zitat Lee P, Weerasuriya DK, Lavori PW, et al. Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007;69(2):328–33.CrossRef Lee P, Weerasuriya DK, Lavori PW, et al. Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007;69(2):328–33.CrossRef
34.
Zurück zum Zitat La TH, Filion EJ, Turnbull BB, et al. Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009;74(5):1335–41.CrossRef La TH, Filion EJ, Turnbull BB, et al. Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009;74(5):1335–41.CrossRef
35.
Zurück zum Zitat Kwiecinski J, Berman DS, Lee SE et al. 2018 Three-hour delayed imaging improves assessment of coronary 18F-sodium fluoride PET. J Nucl Me jnumed.118.217885 published ahead of print September 13. Kwiecinski J, Berman DS, Lee SE et al. 2018 Three-hour delayed imaging improves assessment of coronary 18F-sodium fluoride PET. J Nucl Me jnumed.118.217885 published ahead of print September 13.
Metadaten
Titel
Whole-vessel coronary 18F-sodium fluoride PET for assessment of the global coronary microcalcification burden
verfasst von
Jacek Kwiecinski
Sebastien Cadet
Marwa Daghem
Martin L. Lassen
Damini Dey
Marc R. Dweck
Daniel S. Berman
David E. Newby
Piotr J. Slomka
Publikationsdatum
01.07.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 7/2020
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-019-04667-z

Weitere Artikel der Ausgabe 7/2020

European Journal of Nuclear Medicine and Molecular Imaging 7/2020 Zur Ausgabe